Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
5 Articles
5 Articles

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial…
LifeArc supports research to develop a quick, affordable blood test for the early detection of dementia
As part of a collaboration with UK Dementia Research Institute, we are supporting research to validate a new blood test to detect the earliest signs of neurogenerative conditions, potentially years before symptoms occur. Protein aggregation and associated inflammation play a key role in all neurodegenerative diseases and are known to occur early in disease progression. Professor Sir David Klenerman and his team at the University of Cambridge ar…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium